Sovremennye predstavleniya ob osnovnykh nasledstvennykh faktorakh trombofilii


Cite item

Full Text

Abstract

Multi-factorial diseases (IFPI), brings the greatest share in the structure of the disability and mortality in industrialized
countries. Most buyers of FISALUD medical and social significance, pathology of hemostasis, including trombofiliâ
(enhanced propensity to thrombosis and giperkoagulâcii), occupies one of leading places. Since F2 coagulation factor gene
polymorphisms and F5 and enzyme gene folatnogo cycle (MTHFR MTRR, MTR) are significant risk factors for trombofilii, they
should be included in the survey to assess genetic predisposition to the development of thrombosis.

References

  1. ВОЗ, Информационный бюллетень N°317, Сентябрь 2009 г.
  2. Золкин В.Н., Тищенко И.С. Антикоагулянтная терапия в лечении острых тромбозов глубоких и поверхностных вен нижних конечностей // Трудный пациент, Архив. - 2007. - №15-16. - С. 35-39.
  3. Rouy S., Vidaud D., Alessandri J.-L. et al. Prothrombin Saint-Denis: a natural variant with a point mutation resulting in asp to glu substitution at position 552 in prothrombin // Brit. J. Haemat. - 2006. - Vol. 132. - P. 770-773.
  4. Gehring N. H., Frede U., Neu-Yilik G. et al. Increased efficiency of mRNA 3-prime end formation: a new genetic mechanism contributing to hereditary thrombophilia // Nature Genet. - 2001. -Vol. 28. -P. 389-392.
  5. MartinelliI., Battaglioli T., Bucciarelli P. et al. // Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities // Circulation. -2004. - Vol. 110. - P. 566-70.
  6. Amitrano L., Guardascione M.A., Brancaccio V. et al. // Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. -J Hepatol. -2004. - Vol.40. - P. 736-41.
  7. Lin J., August P. Genetic thrombophilias and preeclampsia: a meta-analysis. - Obstet Gynecol. -2005. - Vol. 105. -P. 182-92.
  8. Баранов В.С. Генетический паспорт - основа индивидуальной и предиктивной медицины, раздел «наследственная тромбофилия». - Санкт-Петербург. Издательство Н-Л. - 2009. - 528с.
  9. Cripe L.D., Moore K.D., Kane W.H. Structure of the gene for human coagulation factor V // Biochemistry. - 1992. - Vol.31. -P. 3777-3785.
  10. van Wijk R., Nieuwenhuis K., van den Berg M. et al. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency // Blood. - 2001. - Vol. 98. - P. 358-367.
  11. Mumford A.D., McVey J.H., Morse C.V. et al. Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C // Brit. J. Haemat. - 2003. -Vol.123. -P. 496-501.
  12. Rosendaal F.R., Reitsma P.H. Genetics of venous thrombosis. - J Thromb Haemost. - 2009. - Vol. 7, Suppl1. - P.301-304.
  13. Ehrenforth S., Nemes L., Mannhalter C. et al. Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V:G1691A. // J Thromb Haemost. - 2004. - Vol. 2. - P. 430-436.
  14. Kist W.J., Janssen N.G., Kalk J.J. et al. Thrombophilias and adverse pregnancy outcome - A confounded problem! //Thromb Haemost.- 2008. - Vol. 99. - P. 77-85.
  15. Dudding T., Heron J., Thakkinstian A. et al. Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis // J Thromb Haemost. - 2008. - Vol. 6. - P. 1869-1875.
  16. Simioni P., Prandoni P., Lensing A.W. et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis // Blood. - 2000. - Vol. 96. - P. 3329-3333.
  17. Junker R., Koch H.G., Auberger K. et al. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia // Arterioscler Thromb Vasc Biol. - 1999. - Vol.19. - P. 2568-2572.
  18. Schobess R., Junker R., Auberger K. et al. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis-evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation // Eur J Pediatr. - 1999. - Vol. 158, - Suppl3. - P. S105-108.
  19. Ehrenforth S., von Depka Prondsinski M., Aygoren-Pursun E. et al. Study of the prothrombin gene 20201 GA variant in FV: Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism // Arterioscler Thromb Vasc Biol. - 1999. - Vol. 19. - P. 276-280.
  20. Трифонова Е.А., Спиридонова М.Г., Пузырев В.П., Степанов В.А. Структура гаплотипов локуса метилентетрагидрофолатредуктазы: популяционная специфичность и ассоциация с атеросклерозом коронарных артерий // Медицинская генетика. - 2009. - №1. - C.39-46.
  21. Зайнулина М.С., Корнюшина Е.А., Глотов А.С. и др. Тромбофилии в акушерской практике: Методические рекомендации / под ред. Айла- мазяна Э.К. и Баранова В.С. - 3-е изд., перераб. и доп. - СПб.: Изд-во Н-Л. - 2009. - С.56.
  22. Kluijtmans L.A.J., WendelU., Stevens E.M.B. et al. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency // Europ. J. Hum. Genet. - 1998. - Vol. 6. - P. 257-265.
  23. Moll S. Thrombophilias-practical implications and testing caveats // J Thromb Thrombolysis. - 2006. - Vol.21, №1. - P.7-15.
  24. Hustad S., Midttun O., Schneede J. et al. The methylenetetrahydrofolate reductase 677C-T polymorphism as a modulator of a B vitamin network with major effects on homocysteine metabolism // Am. J. Hum. Genet. - 2007. - Vol. 80. - P.846-855.
  25. Wilcken B., Bamforth F., Li Z. et al. Geographical and ethnic variation of the 677C-T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 newborns from 16 areas world wide // J. Med. Genet. - 2003. - Vol. 40. - P.619-625.
  26. Klerk M., Verhoef P., Clarke R. et al. MTHFR Studies Collaboration Group MTHFR 677C-T polymorphism and risk of coronary heart disease: a metaanalysis // JAMA. - 2002. - Vol. 288. - P. 2023-2031.
  27. Kluijtmans L.A.J., van den Heuvel L.P.W.J., Boers G.H.J. et al. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease // Am. J. Hum. Genet. - 1996. - Vol.58. - P.35-41.
  28. Qian X., Lu Z., Tan M. et al. A meta-analysis of association between C677T polymorphism in the methylenetetrahydrofolate reductase gene and hypertension // Europ. J. Hum. Genet. - 2007. - Vol. 15. - P. 1239-1245.
  29. Mills J.L., McPartlin J.M., Kirke P.N. et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects // Lancet. - 1995. - Vol.345. - P.149-151.
  30. Motulsky A.G. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid // Am. J. Hum. Genet. - 1996. - Vol. 58. - P. 17-20.
  31. Reyes-Engel A., Munoz E., Gaitan M.J. et al. Implications on human fertility of the 677C-T and 1298A-C polymorphisms of the MTHFR gene: consequences of a possible genetic selection // Molec. Hum. Reprod. - 2002. - Vol. 8. - P. 952-957.
  32. Zhu J., Ren A., Hao L. et al. Variable contribution of the MTHFR C677T polymorphism to non-syndromic cleft lip and palate risk in China // Am. J. Med. Genet. - 2006. - Vol.140A. - P.551-557.
  33. Mostowska A., Hozyasz K.K., Jagodzinski P.P. Maternal MTR genotype contributes to the risk of non-syndromic cleft lip and palate in the Polish population // Clin. Genet. - 2006. - Vol.69. - P.512-517.
  34. Gaspar D.A., Matioli S.R., de Cassia Pavanello R. et al. Maternal MTHFR interacts with the offspring's BCL3 genotypes, but not with TGFA, in increasing risk to nonsyndromic cleft lip with or without cleft palate // Europ. J. Hum. Genet. - 2004. - Vol.12. - P.521-526.
  35. Nygard O., Vollset S.E., Refsum H. et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study // JAMA. - 1995. - Vol. 274. - P. 1526-33.
  36. Boushey C.J., Beresford S.A., Omenn G.S., Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes // JAMA. - 1995. - Vol.274. - P.1049-1057.
  37. Botto L.D. & Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: A HuGE review // Am J Epidemiol - 2000. - Vol. 151, № 9. - P. 862-877.
  38. O'Leary V.B., Parle-McDermott A., Molloy A.M. et al. MTRR and MTHFR polymorphism: link to Down syndrome? // Am. J. Med. Genet. - 2002. - Vol. 107. - P. 151-155.
  39. Hobbs C.A., Sherman S.L., Yi P. et al. Polymorphisms in genes involved in folate metabolism as maternal risk factors for Down syndrome // Am. J. Hum. Genet. - 2000. - Vol. 67. - P. 623-630.
  40. Boduroglu K., Alanay Y., Koldan B., Tuncbilek E. Methylenetetrahydrofolate reductase enzyme polymorphisms as maternal risk for Down syndrome among Turkish women // Am. J. Med. Genet. - 2004. - Vol. 127A. - P. 5-10.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Litvinova M.M., Subbotina T.I., Maklygina Y.Y., Zhuchenko N.A., Filipova M.G., Filipova T.V., Asanov A.Y.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies